Phase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/B
Clinical trial NCT01940315 · WITHDRAWN
Trial details
- NCT number
- NCT01940315
- Sponsor
- DynPort Vaccine Company LLC, A GDIT Company
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-01
- Primary completion
- 2019-03-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.